A Response To: Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions
published in: Diabetes Therapy
date of publication: 2020-10-14
main subject: COVID-19, COVID-19-related data
Cites articles
There is nothing here
Article - wd:Q100535432